NO964896L - Fremgangsmåte for immunmodulering ved hjelp av adoptiv overföring av antigenspesifikke, cytotoksiske T-celler - Google Patents

Fremgangsmåte for immunmodulering ved hjelp av adoptiv overföring av antigenspesifikke, cytotoksiske T-celler

Info

Publication number
NO964896L
NO964896L NO964896A NO964896A NO964896L NO 964896 L NO964896 L NO 964896L NO 964896 A NO964896 A NO 964896A NO 964896 A NO964896 A NO 964896A NO 964896 L NO964896 L NO 964896L
Authority
NO
Norway
Prior art keywords
antigen
cells
ctls
immunomodulation
specific cytotoxic
Prior art date
Application number
NO964896A
Other languages
English (en)
Other versions
NO964896D0 (no
NO319331B1 (no
Inventor
Claudio Bordignon
Fulvio Mavilio
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO964896L publication Critical patent/NO964896L/no
Publication of NO964896D0 publication Critical patent/NO964896D0/no
Publication of NO319331B1 publication Critical patent/NO319331B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19964896A 1994-05-16 1996-11-18 Fremgangsmate for fremstilling av terapeutisk middel bestaende av antigenspesifikke, cytotoksiske T-celler. NO319331B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/001573 WO1995031208A1 (en) 1994-05-16 1994-05-16 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells

Publications (3)

Publication Number Publication Date
NO964896L true NO964896L (no) 1996-11-18
NO964896D0 NO964896D0 (no) 1996-11-18
NO319331B1 NO319331B1 (no) 2005-07-18

Family

ID=8165855

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964896A NO319331B1 (no) 1994-05-16 1996-11-18 Fremgangsmate for fremstilling av terapeutisk middel bestaende av antigenspesifikke, cytotoksiske T-celler.

Country Status (11)

Country Link
EP (1) EP0804210B1 (no)
JP (1) JP3288708B2 (no)
KR (1) KR100219258B1 (no)
AT (1) ATE228368T1 (no)
AU (1) AU691501B2 (no)
DE (1) DE69431808T2 (no)
DK (1) DK0804210T3 (no)
ES (1) ES2186686T3 (no)
NO (1) NO319331B1 (no)
PT (1) PT804210E (no)
WO (1) WO1995031208A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063375A (en) * 1996-09-10 2000-05-16 Medical University Of South Carolina Semiallogeneic cell hybrids and related methods for treating cancer
GB0224442D0 (en) 2002-10-21 2002-11-27 Molmed Spa A delivery system
KR100882445B1 (ko) 2007-03-16 2009-02-09 울산대학교 산학협력단 항―４－１ｂｂ 항체를 이용한 항원 특이적 자가유래ｃｄ８＋ｔ 세포의 분리 및 증식 방법
EP3101122B1 (en) 2009-08-24 2023-06-14 Baylor College of Medicine Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
PL3591047T3 (pl) 2012-02-09 2022-12-05 Baylor College Of Medicine Mieszanki peptydowe do wytwarzania wielowirusowych ctl o szerokiej swoistości
EP3350600A4 (en) 2015-09-18 2019-04-17 Baylor College of Medicine DISTINCTION OF AN IMMUNOGENIC ANTIGEN OF A PATHOGEN AND CORRELATION WITH CLINICAL EFFECTIVENESS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005262A1 (en) * 1990-09-14 1992-04-02 The John Hopkins University Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
US5529774A (en) * 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells

Also Published As

Publication number Publication date
DE69431808T2 (de) 2003-09-18
EP0804210B1 (en) 2002-11-27
DK0804210T3 (da) 2003-03-10
KR100219258B1 (ko) 1999-09-01
ES2186686T3 (es) 2003-05-16
JPH09507643A (ja) 1997-08-05
PT804210E (pt) 2003-04-30
EP0804210A1 (en) 1997-11-05
AU691501B2 (en) 1998-05-21
JP3288708B2 (ja) 2002-06-04
NO964896D0 (no) 1996-11-18
WO1995031208A1 (en) 1995-11-23
DE69431808D1 (de) 2003-01-09
NO319331B1 (no) 2005-07-18
ATE228368T1 (de) 2002-12-15
AU6928194A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
WO2001051616A3 (en) Techniques for growth and differentiation of human pluripotent stem cells
AU2528797A (en) Cell culture media for mammalian cells
PL335723A1 (en) Hair breeding method
NO964896D0 (no) Fremgangsmåte for immunmodulering ved hjelp av adoptiv overföring av antigenspesifikke, cytotoksiske T-celler
DE69919531D1 (de) Aus normalem menschlichem hautgewebe immortalizierte zellinien
CA2069541A1 (en) Induction of an antigen-specific t-lymphocyte response
CN109402045A (zh) 一种水牛精原干细胞样细胞的体外培养及传代方法
CA2190261A1 (en) Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
EP0061253A3 (en) Process for the transfer of genetic material into actinomycete cells, prepared cells and method of culturing these cells and isolating a metabolite
Sauer et al. Methane synthesis by membrane vesicles and a cytoplasmic cofactor isolated from Methanobacterium thermoautotrophicum
AU2088997A (en) Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway
AU570954B2 (en) Propagation of proliferating cell aggregates
CN104164365A (zh) 一种体外细胞接触式共培养装置及其培养操作方法
Wilson et al. Biochemistry of hybridoma technology
EP0855441A3 (en) Isolation and purification of germinal stem cell using magnetic bead functioning as antibody and method for establishing stem cell line
CN109385395A (zh) 一种用于体外培养的水牛精原干细胞样细胞的纯化方法
SLASHCHEVA et al. Effect of space flight factors on Chlorella(Vliianie faktorov kosmicheskogo poleta na khlorellu)
CN117384830A (zh) 高效制备无异源成分iPSCs的方法
JPS56140888A (en) Preparation of limiting enzyme
EP0869173B8 (de) Träger für Zellkulturen
MX9707195A (es) Metodo de cultivo celular.
TW364924B (en) Three new cell lines derived from pupal ovaries of Spodoptera litura
UA8653A1 (uk) Спосіб одержаhhя бактеріородопсиhу

Legal Events

Date Code Title Description
MK1K Patent expired